House Science Committee Holds Hearing On COVID-19 Vaccines and Encouraging Uptake

On February 19, the House Committee on Science, Space and Technology held a hearing on “The Science of COVID-19 Vaccines and Encouraging Vaccine Uptake.” The Committee heard testimony from Professor in Vaccinology and Director at the Center for Vaccine Development and Global Health Dr. Kathleen Neuzil, Director and Health Authority at the Dallas County Department of Health and Human Services Dr. Philip Huang, Deputy Commissioner at the Oklahoma State Department of Health Keith Reed, and the Scientific Director at the Center for Health Incentives and Behavioral Economics and Associate Professor of Nursing and Health Policy at the University of Pennsylvania School of Nursing Dr. Alison Buttenheim. The hearing was overseen by Chairwoman Eddie Bernice Johnson (D-TX) and Ranking Member Frank Lucas (R-OK).

Throughout the hearing, varying were views expressed over whether supply or demand of vaccines should be the focus. Dr. Huang reminded the Committee that vaccine hesitancy remains an issue, and Dr. Neuzil advocated for more investment into social science research for a better understanding of vaccine hesitancy. Dr. Buttenheim and Dr. Huang both advocated for removing logistical hurdles preventing citizens from getting discouraged by protocols. The witnesses also criticized the framing of “Operation Warp Speed,” the government’s vaccine development and distribution initiative, as a potential contributor to public fear of the speed of vaccine development. They also cautioned against proposing incentives for vaccination, on the grounds that it would send the wrong message around vaccines.

There was also discussion around differences between the several versions of the vaccine and how citizens could be overwhelmed by choosing which vaccine to take. Dr. Buttenheim advocated for reducing the cognitive load for citizens by bringing all authorized COVID-19 vaccines under one label like influenza vaccines. Two Committee members, Mike Garcia (R-CA) and Randy Weber (R-TX), raised concerns over this approach—Garcia agreed with the science behind the reasoning, but believed this could do more harm than good in the long-term. Every witness agreed that communication coming from local and trusted medical leaders must be clear and consistent to allow diverse strategies that best serve the populations equitably and build long-term confidence. Dr. Buttenheim laid out specific strategies in her written testimony. The hearing is available on the Committee on Science, Space, & Technology’s website.

This article was contributed by Nicholas Lynn, COSSA’s spring intern.


Past Newsletters



Browse 40 years of the COSSA Washington Update.